Effects of Epigenetic Regulation in Chronic Pelvic Pain Syndrome
CompletedNCT05185180
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study seeks to identify defects in immune activation or regulation that may affect a subset of patients with CP/CPPS. This subset appears to have a reduced ability to mount a regulatory immune response, while simultaneously eliciting an exaggerated activated immune response. The defects that we demonstrate appear to be linked to altered methylation of genes involved in both immune regulation and immune activation. The aims of this study will provide definitive evidence of a role for epigenetic changes in immune cells in patients with CP/CPPS.
Study details
- Official title
- Effects of Epigenetic Regulation in Chronic Pelvic Pain Syndrome
- Conditions
- Sponsor
- Northwestern University
- Start date
- 2021-10-11
- Primary completion
- 2023-03-07
- Sex
- Male
- Age range
- from 21 Years to 80 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: Inclusion Criteria for Control Group: • Healthy males ages 21-80 years old Exclusion Criteria: Exclusion Criteria for Control Group: * Females * Males \<21 and \>80 years old * Patients with impaired renal or hepatic function.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05185180